HSV1 viremia with fulminant hepatitis as opportunistic sequela in severe COVID-19

Ann Hematol. 2022 Jan;101(1):229-231. doi: 10.1007/s00277-021-04417-y. Epub 2021 Jan 18.
No abstract available

Publication types

  • Case Reports
  • Letter

MeSH terms

  • Acyclovir / therapeutic use
  • Antiviral Agents / therapeutic use
  • COVID-19 / complications*
  • COVID-19 / pathology
  • COVID-19 / therapy
  • Disease Management
  • Herpes Simplex / complications*
  • Herpes Simplex / pathology
  • Herpes Simplex / therapy
  • Herpesvirus 1, Human / drug effects
  • Herpesvirus 1, Human / isolation & purification*
  • Humans
  • Intensive Care Units
  • Male
  • Massive Hepatic Necrosis / complications*
  • Massive Hepatic Necrosis / pathology
  • Massive Hepatic Necrosis / therapy
  • Middle Aged
  • SARS-CoV-2 / drug effects
  • SARS-CoV-2 / isolation & purification
  • Severity of Illness Index
  • Viremia / complications*
  • Viremia / pathology
  • Viremia / therapy

Substances

  • Antiviral Agents
  • Acyclovir